RecallHawk

Atellica® CH Diazo Direct Bilirubin (D_DBil)

Siemens Healthcare Diagnostics, Inc.

Summary

Siemens Healthcare Diagnostics, Inc. received 510(k) clearance for Atellica® CH Diazo Direct Bilirubin (D_DBil), a CIG device. Cleared on 2023-06-12.

Details

Source

510(k) Clearance

External ID

K223078

Action Date

2023-06-12

Status

Traditional

Category

device

Product Code

CIG

Product Description

Atellica® CH Diazo Direct Bilirubin (D_DBil). Product code: CIG.

Context & Analysis

A 510(k) clearance means the FDA determined this device is substantially equivalent to a legally marketed device. This is one of 403 device clearances issued this month. Siemens Healthcare Diagnostics, Inc. has received 24 total clearances in our database.

Siemens Healthcare Diagnostics, Inc. has 166 FDA actions in our database, including 142 recalls and 24 clearances.

Frequently Asked Questions

What does 510(k) clearance mean?

A 510(k) is an FDA premarket submission demonstrating that a device is substantially equivalent to a legally marketed device. It does NOT mean FDA approval — it means the device is cleared for marketing because it's similar enough to an existing cleared device. Most medical devices reach market via 510(k) rather than full PMA approval.

How often does Siemens Healthcare Diagnostics, Inc. have FDA actions?

Siemens Healthcare Diagnostics, Inc. has 166 FDA actions in our database, including 142 recalls and 24 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "K223078" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions